Poseida Therapeutics, Inc. Common Stock (PSTX)

PSTX was delisted on the 7th of January, 2025.

• Market cap: $926M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

Employees: 350